Literature DB >> 468986

Properdin factor D: effects on thrombin-induced platelet aggregation.

A E Davis, D M Kenney.   

Abstract

Factor D, when preincubated with platelet suspensions, at concentrations as low as 1.2 micrograms/ml, inhibited thrombin-induced platelet aggregation. No inhibition of collagen or arachidonic acid-induced platelet aggregation was found. Inhibition occurred, but to a lesser extent, when thrombin and factor D were added to platelets at the same time. No inhibition occurred when factor D was added after thrombin. Thrombin was able to overcome inhibition by factor D by increasing its concentration. Diisopropyl-phosphorofluoridate-inactivated factor D also inhibited thrombin-induced platelet aggregation so that enzymatic activity of factor D was not required for inhibition. Factor D absorbed with hirudin coupled to Sepharose 6B showed no decrease in inhibitory capacity. 125I-Factor D bound to platelets in a manner suggesting an equilibrium reaction similar to thrombin. At low factor D input, binding was linear, whereas at higher input, binding began to approach saturation. Binding of 125I-labeled thrombin to platelets was inhibited by factor D. Analysis of these data show that factor D does not alter the total number of thrombin molecules which bind to the platelet surface at saturation. However, the dissociation constant for thrombin is altered from 2.78 to 6.90 nM in the presence of factor D (20 micrograms/ml). Factor D is thus a competitive inhibitor of thrombin binding, although the affinity of factor D for the platelet thrombin receptor is much less than that of thrombin. These phenomena occur at physiologic concentrations of factor D. Therefore, factor D may function in vivo as an inhibitor of platelet aggregation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 468986      PMCID: PMC372173          DOI: 10.1172/JCI109515

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  THE BINDING OF KIDNEY-BEAN PHYTOHEMAGGLUTININ BY EHRLICH ASCITES CARCINOMA.

Authors:  T L STECK; D F HOELZLWALLACH
Journal:  Biochim Biophys Acta       Date:  1965-03-08

2.  Lactic dehydrogenase activity in blood.

Authors:  F WROBLEWSKI; J S LADUE
Journal:  Proc Soc Exp Biol Med       Date:  1955-10

3.  Human factor D of the alternative complement pathway: purification and characterization.

Authors:  J E Volanakis; R E Schrohenloher; R M Stroud
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

4.  Equilibrium binding of thrombin to platelets.

Authors:  B M Martin; W W Wasiewski; J W Fenton; T C Detwiler
Journal:  Biochemistry       Date:  1976-11-02       Impact factor: 3.162

5.  Mechanism of complement-mediated activation of human blood platelets in vitro: comparison of normal and paroxysmal nocturnal hemoglobinuria platelets.

Authors:  R H Dixon; W F Rosse
Journal:  J Clin Invest       Date:  1977-02       Impact factor: 14.808

6.  Structure-function relationships in the interaction of alpha-thrombin with blood platelets.

Authors:  E F Workman; G C White; R L Lundblad
Journal:  J Biol Chem       Date:  1977-10-25       Impact factor: 5.157

7.  Responses of human platelets to immunologic stimuli: independent roles for complement and IgG in zymosan activation.

Authors:  S E Martin; R T Breckenridge; S I Rosenfeld; J P Leddy
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

8.  Hereditary C5 deficiency in man. III. Studies of hemostasis and platelet responses to zymosan.

Authors:  R T Breckenridge; S I Rosenfeld; K S Graff; J P Leddy
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

9.  Mechanism of action of factor D of the alternative complement pathway.

Authors:  P H Lesavre; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

10.  The human complement system in thrombin-mediated platelet function.

Authors:  M J Polley; R Nachman
Journal:  J Exp Med       Date:  1978-06-01       Impact factor: 14.307

View more
  5 in total

Review 1.  The role of complement in immune clearance of blood cells.

Authors:  U E Nydegger; M D Kazatchkine
Journal:  Springer Semin Immunopathol       Date:  1983

2.  Regulation of the activity of platelet-bound C3 convertase of the alternative pathway of complement by platelet factor H.

Authors:  D V Devine; W F Rosse
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

Review 3.  Platelet mediated complement activation.

Authors:  Ellinor I B Peerschke; Wei Yin; Berhane Ghebrehiwet
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

4.  Protective role for properdin in progression of experimental murine atherosclerosis.

Authors:  Tanja Steiner; Lorenza Francescut; Simon Byrne; Timothy Hughes; Archana Jayanthi; Irina Guschina; John Harwood; Katherine Cianflone; Cordula Stover; Sheila Francis
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

Review 5.  Complement in Hemolysis- and Thrombosis- Related Diseases.

Authors:  Shanshan Luo; Desheng Hu; Moran Wang; Peter F Zipfel; Yu Hu
Journal:  Front Immunol       Date:  2020-07-10       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.